Dr Reddy’s Moves Ahead With Global Rituximab Filings

US FDA, EMA And MHRA Accept Firm’s Rituxan/MabThera Biosimilar Rival For Review

 
• By David Wallace
  
Dr Reddy's logo on website under magnifying glass
Dr Reddy’s has filed rituximab with multiple regulators • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products